Record profits mask volume miss; margins unsustainable

Revenue ₹526 Cr (+40% YoY), PAT ₹79 Cr (+311% YoY), EBITDA ₹117 Cr — all records confirmed

Overall volume down 10-12% YoY; domestic +10%, export -30%+ (MENA disruption). Volumes did not grow

OPM 22.3% this quarter vs prior FY26 average ~10-11%, corroborating statement but management hedges: ~2% from inventory gains (one-time), sustainable level 15-16%

Despite 10-12% volume drop, profitability surged via realization gains, inventory timing, and supply constraints. Dual fuel sources, multi-source procurement enabled continuity

Only 15-20% cash outflow so far (civil works); NBR timeline firm (April 2027), SB latex end-Q1 or June 2027. Deferred to Q3-Q4 for equipment delivery

Prior guidance 'low double-digit volume growth'; Q1 actual −10-12% YoY. Export disruption (MENA) blamed as temporary but magnitude unexpected.

22.3% OPM presented as record but management consistently caveats: 15-16% 'average margins', current quarter has 'favorable timing benefit' (inventory ~2%), won't annualize.

₹220 Cr capex cost reduced from prior 200-250 Cr estimate via 'innovative debottlenecking'; ROI justified despite prior hesitation on NBR expansion economics.

Management withheld decision on second nitrile latex expansion; waiting 3-4 months to assess margin trajectory and global capacity (China, Malaysia) impact.

No quantified FY27 revenue or margin target restated; 'ambitious growth targets' mentioned but deferred to future calls. Repeated 'wait 3-4 months' hedging.

~2% EBITDA margin from inventory gains; overall volume down 10-12% YoY but domestic +10% (exports hit by Strait of Hormuz closure). Expects recovery once war ends.

Confident of 15-16% average margins. Few quarters lower, few higher. Current 22% not annualizable; Q1 was exceptional timing. Unsure on 'normalized' baseline.

NBR: Q1 FY28 (April); SB latex: couple months after (June/July). Total ₹220 Cr for both projects.

Intentional operational resilience: dual fuel sources (coal/gas), multiple raw material suppliers, quick procurement decisions (vs. MNCs), proven this quarter. Competitive moat from flexibility.

Planned capex adds ~₹600 Cr (~40% growth). Further investments possible if market supports. No reason to rule out doubling, but no commitment yet. Balance sheet net cash supports it.

Favorable timing benefit from supply constraints and inventory gains. Not annualizable. Core strength: risk management and procurement capability will persist; margins should improve with scale. Dumping risks managed.

₹220 Crores for both NBR and SB latex expansions.

₹4 Cr one-time impairment provision in Q4. Q4 typically high-maintenance quarter with repair costs. Q1 benefited from lower maintenance.

Project plan ready to go. Waiting 3-4 months to assess margin trajectory; China capacity, Malaysia expansions also coming. Will take a call shortly. Investment cost and volume benefits known.

Net cash ₹30-40 Cr (down from ₹70 Cr in March due to WC increase). Only 15-20% capex spent (civil works & advances); equipment delivery Q3-Q4.

Two factors: (1) Capex cost reduced 200-250 Cr → 130-135 Cr via innovative debottlenecking (game-changer); (2) Margins improving, no major NBR expansions globally, ROI now justified.

Post-COVID: demand super-strong (100% capacity, good margins for 2-3 years). Then global overcapacity added, nitrile overcapacity from glove industry disruption. Now normalizing. Q1 exceptional due to timing, not structural.

Days of inventory hold same as Q4, but value increased due to higher RM prices. Quantities unchanged.

Demand strong across domestic (paper, construction, rubber, goods). Exports less impacted except MENA. Realization volatile (oil-linked); impossible to predict net realization. High crude has not dented domestic demand.

Rupee move doesn't significantly help; all RMs also dollar-denominated. So depreciation helps on finished goods pricing but hurts on RM costs — net zero.

In Q1 they were above 15%. But FY25-26 didn't reach that level overall (nitrile dragged). Too early to say if trend sustained; waiting 3-4 months.

Q1 FY27 saw −10-12% volume YoY. Domestic +10% insufficient to offset −30%+ export collapse (MENA). Guidance already missed in Q1; management withheld FY27 numeric restatement.

NBR: 100% capacity add for ₹130-135 Cr capex (Q1 FY28 online). SB latex: additional ~200 Cr revenue. Timeline firm (Apr-Jun 2027), cost locked in.

Q1 delivered 22.3% OPM, far above FY26 avg (~10-11%). But management hedges: ~2% from inventory timing, sustainable 15-16% 'average' implies significant normalization coming.

Management confident but caveat-heavy. Relies on nitrile cycle recovery (emerging from trough), scale benefits, and operational leverage. Doesn't assume abnormal spreads or RM pricing cycles.

Prior guidance reaffirmed. NBR firm (April 2027), SB latex few months after. Only 15-20% cash spend so far; major equipment delivery Q3-Q4 FY27.

Exports down −30%+ in Q1 due to Strait of Hormuz closure and West Asia tensions. MENA is strategic region for Apcotex. Recovery dependent on war de-escalation; no visibility.

22.3% OPM Q1 includes ~2% inventory timing gain (non-recurring), favorable RM spreads (crude-linked, volatile), and supply scarcity benefits. Management consistently states 15-16% 'average' margins; implies 6-7pp normalization risk.

Nitrile latex market still in overcapacity mode post-COVID (3-4 yrs later). Q1 margins improved above 15% but may be false signal (overall supply scarcity tilting spreads). Management hedges: 'wait 3-4 months' to see if recovery sustained. No guarantee.

Q1 FY27 volume down −10-12% YoY, contradicting prior guidance. Management blamed export disruption (temporary) but magnitude unexpect. If MENA disruption persists longer or domestic demand softens (Q2 monsoon risk), FY27 volume growth unlikely.

Net cash down from ₹70 Cr (Mar 2026) to ₹30-40 Cr (Jun 2026). WC up due to higher RM prices inflating inventory/receivables (quantity flat, value up). Major capex outflows (₹220 Cr) coming in Q3-Q4 FY27. If margins compress or volumes stay weak, liquidity stress possible.